Company: RVRC
Filing Date: 2025-10-03
Form Type: S-1/A
Source: 0001213900-25-096094
Chunk: 48

Company: Revium Rx.
Filing Date: 2025-10-03
Form: S-1/A
Chunk 48
---
 the OTCID tier is often thin and characterized by wide fluctuations in trading prices, due to many factors that may have little
to do with our operations or business prospects. The securities market has from time to time experienced significant price and volume
fluctuations that are not related to the operating performance of particular companies. These market fluctuations may also materially
and adversely affect the market price of shares of our Common stock. Moreover, the OTC Market is not a stock exchange and is not an established
market, and trading of securities on the OTCID is often more sporadic than the trading of securities listed on a national stock exchange
like the NYSE. Accordingly, you may have difficulty reselling any shares of Common Stock.

The trading market for our Common Stock will be influenced by the research and reports that equity research analysts publish about us and our business.

The price of our Common Stock could decline if
one or more securities analysts downgrade our Common Stock or if those analysts issue a sell recommendation or other unfavorable commentary
or cease publishing reports about us or our business. If one or more of the analysts who elect to cover us downgrade our common shares,
our share price could decline rapidly. If one or more of these analysts cease coverage of us, we could lose visibility in the market,
which in turn could cause our share price and trading volume to decline.

<div align='center'>25</div>

We do not intend to pay dividends on our Common Stock.

We intend to retain all of our earnings, if any,
for the foreseeable future to finance the operation and expansion of our business and do not anticipate paying cash dividends. Any future
determination to pay dividends will be at the discretion of our board of directors, subject to compliance with applicable law and any
contractual provisions, and will depend on, among other factors, our results of operations, financial condition, capital requirements
and other factors that our board of directors deems relevant. As a result, you should expect to receive a return on your investment in
our Common Stock only if the market price of the Common Stock increases, which may never occur.

Risks Relating to this Offering

Since this is a self-underwritten offering by the Company, no independent third party such as an underwriter conducted any due diligence on the accuracy of the information in this prospectus.

In an underwritten offering, the underwriter conducts
an independent due diligence of the company. Since there is no underwriter in this Primary Offering, none of the information contained
in the registration statement of